Insiders Genovis AB

Equities

GENO

SE0002485979

Delayed Nasdaq Stockholm Other stock markets 11:39:27 28/06/2024 BST			5-day change	1st Jan Change
28.3 ^SEK	-1.91%		-1.05%	-45.58%

05-15	Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-14	Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genovis AB (Publ.) Announces Board Changes	12/05/22	CI
Genovis' : New CFO To Assume Role January 2022	06/10/21	MT
Genovis AB (Publ.) Announces Executive Changes	20/05/21	CI
Genovis : CFO has resigned	29/03/21	AQ
Genovis Announces the Resignation of Johny Humaloja as its Chief Financial Officer	29/03/21	CI
Genovis AB Elects Torben Jørgensen as Chairperson of the Board	05/05/20	CI
Genovis publ : Nomination Committee proposes Torben Jørgensen for new chairman of Genovis	23/03/20	AQ
Genovis AB Announces That Sarah Fredriksson Stepped Down as Chair of the Board	23/03/20	CI
Genovis AB Announces Board Changes	20/12/19	CI
Genovis AB Proposes the Resignation of Mårten Winge from the Board	04/12/19	CI
Genovis AB Announces Board Changes	23/05/19	CI
Genovis AB Announces Lena Mårtensson Wernrud Has Declined Re-Election	10/04/19	CI
Genovis AB Appoints Rob Horsefield as Sales & Business Development Manager	27/11/18	CI
Genovis AB Approves Election of Lena Söderström och Peter Hein as Board Member	17/05/18	CI
Genovis Announces Board Changes	23/04/18	CI
Genovis AB Announces Board Changes	13/05/16	CI
Genovis Announces Management Changes	04/05/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer